EROPP
Survey on Representations, Opinions and Perceptions regarding Psychoactive Drugs
The EROPP survey measures the French population's opinions and perceptions pertaining to psychotropic drugs and the related public actions. The 2013 survey was the fourth. The first three were conducted in 1999, 2002 and 2008. This telephone survey was based on a randomly surveyed, representative sample of the French population aged 15 to 75 years. The sample comprised households with a landline telephone (2,200) and people who used mobile phones only (300 individuals). The data were collected between 27 October and 25 December 2012.
The individuals were questioned about their use, their perception of the level of danger to health, their perception of users and public legal and illegal drug policies.
Results
Ten years of change in French people's perceptions and opinions regarding drugs (1999-2008)
Tendances N° 71, August 2010
Drugs and public policies : changes in perceptions and opinions, 1999-2002
Tendances N° 28, January 2003
How do the French perceive heroin users?
Tendances N° 8, June 2000
Drugs and Drug Addiction, perceptions and opinions in 1999: First Results
Tendances N° 4, December 1999
Drugs in Europe
2023 EMCDDA European Drug Report
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.